[1]ChemMedChem,2019,vol.14,p.1000-1004
Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
Journal: Bioorganic & medicinal chemistry letters 20101101
16879-68-8
28547-16-2
37028-84-5
26638-45-9
199181-50-5
52109-67-8 | 2,3-Dicyano-6-methyl-5-phenylpyrazine | AA00DIQ1 | MFCD05863478
448233-17-8 | N-(3-(Trifluoromethyl)phenyl)hydrazinecarboxamide | AA00DIX0 | MFCD01869439
54404-01-2 | 2-Bromo-4-chlorobenzenethiol | AA00DJ8X | MFCD18089363
536974-94-4 | (4-(Benzyloxy)-3-fluorophenyl)methanol | AA00DJKG | MFCD11190327
54631-37-7 | (S)-2-Amino-4-oxo-4-phenylbutanoic acid hydrochloride | AA00DJSB | MFCD29038825
53657-94-6 | 1-(2-Amino-3-methylphenyl)ethanone | AA00DK2Q | MFCD00129145
53965-69-8 | 4-Bromo-2,3,5,6-tetramethylaniline | AA00DKD3 | MFCD09260833
54609-08-4 | 1-(4-Fluorophenyl)-2,5-dimethylpyrrole | AA00DKII | MFCD01910971
444583-13-5 | 2-(2-(tert-Butoxycarbonyl)isoindolin-1-yl)acetic acid | AA00DKPH | MFCD13195382
431900-65-1 | 7,10,13,16-Tetraoxa-1,3-disilaheptadecane, 1,1,1,3,3-pentachloro- | AA00DL1Z